The Performance of Patient Support Program in Early Stage Breast Cancer

Survey Conducted Among Early Breast Cancer Patients Treated With Arimidex for Evaluation of Treatment Adherence

NCT01081509 ·Status: COMPLETED

Adherence of Hispanic / Latina Breast Cancer - Patients to Adjuvant Aromatase Inhibitors

NCT03144037 ·Status: COMPLETED

Interactive Care Plan for the Monitoring of Symptoms and Recovery in Patients With Stage 0-III Breast Cancer

NCT04693338 ·Status: COMPLETED ·Phase: PHASE1

Maintenance Hormone Therapy for Postmenopausal HR Positive Advanced Breast Cancer

NCT02000193 ·Status: UNKNOWN ·Phase: PHASE2

Clinical Study of Adjuvant Therapy on Post-menopausal Women With Breast Cancer Under the Guidance of the Results of Preoperative Endocrinotherapy

NCT01613560 ·Status: UNKNOWN ·Phase: PHASE2

A Prospective Observational Study About Adjuvant or Neoadjuvant Chemotherapy Related Adverse Effects in Postmenopausal Breast Cancer Patients

NCT03543072 ·Status: UNKNOWN

Adjuvant Ovarian Suppression Plus Aromatase Inhibitor or Tamoxifen in Young Women

NCT02914158 ·Status: RECRUITING ·Phase: PHASE3

The Anti-tumor Effect of Metformin And Atorvastatin in Breast Cancer

NCT05507398 ·Status: UNKNOWN ·Phase: PHASE4

Efficacy of Tamoxifen Versus Toremifene in CYP2D6 IM/PM of Premenopausal Patients With ER-positive Early Breast Cancer

NCT03351062 ·Status: RECRUITING ·Phase: PHASE3

A Phase III Trial Comparing HRS-8080 With Standard Endocrine Therapy in Patients With Intermediate or High Risk Early Breast Cancer

NCT07349069 ·Status: RECRUITING ·Phase: PHASE3

APOLLO(Aromatase Inhibitor Patient cOmpLiance Program With qoL Questionaire)

NCT00523315 ·Status: COMPLETED

Study of Arimidex and Radiotherapy Sequencing

NCT01402193 ·Status: UNKNOWN ·Phase: PHASE3

Neoadjuvant Aromatase Inhibitor(AI) With Ovarian Suppression Versus Chemotherapy in Premenopausal Breast Cancer Patients

NCT02532400 ·Status: TERMINATED ·Phase: PHASE3

Steroid Aromatase Inhibitors Versus Progestogens for nSAID-resistanced Late Stage Breast Cancer

NCT02161315 ·Status: UNKNOWN

The Effect of Aromatase Inhibitors on Cardiovascular Risk Factors in Women With Breast Cancer

NCT01080170 ·Status: COMPLETED

CDK4/6 Inhibitors Combined With Standard Adjuvant Endocrine Therapy in High-Risk, HR+/HER2+ Early Breast Cancer Patients(CHESS)

NCT07019363 ·Status: RECRUITING ·Phase: PHASE3

Low-dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor-negative Early Breast Cancer

NCT00022516 ·Status: COMPLETED ·Phase: PHASE3

Comparative Evaluation of Efficacy and Safety of Toremifene, Tamoxifen, and Aromatase Inhibitor Plus Ovarian Function Suppression in Hormone Receptor-Positive Early Breast Cancer Among Non-Low-Risk Premenopausal Women: A Real-World Study

NCT05801705 ·Status: UNKNOWN

Impact of Obesity on the Efficacy of Endocrine Therapy With Aromatase Inhibitors

NCT01758146 ·Status: UNKNOWN ·Phase: PHASE3

Increasing Oral Medication Adherence for Metastatic Breast Cancer Patients

NCT06726889 ·Status: RECRUITING

CONcurrent vs SEqueNTial Adjuvant Treatments in Early Breast Cancer

NCT02918084 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Pilot Study of a an App to Improve Medication Adherence in Breast Cancer Survivors Receiving AIs

NCT04170920 ·Status: COMPLETED ·Phase: NA

Efficacy of High Dose Tamoxifen to Advanced Hormone Receptor-High Expressed Breast Cancer

NCT03045653 ·Status: COMPLETED ·Phase: PHASE2

Expectations and Side Effects of Endocrine Therapy in Women With Breast Cancer

NCT02088710 ·Status: UNKNOWN

Web-Base App To Improve Aromatase Inhibitor Adherence

NCT02957526 ·Status: COMPLETED ·Phase: NA